I. Lavi

1.5k total citations
23 papers, 1.1k citations indexed

About

I. Lavi is a scholar working on Epidemiology, Rheumatology and Oncology. According to data from OpenAlex, I. Lavi has authored 23 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 6 papers in Rheumatology and 4 papers in Oncology. Recurrent topics in I. Lavi's work include Spondyloarthritis Studies and Treatments (3 papers), Urinary Tract Infections Management (3 papers) and Rheumatoid Arthritis Research and Therapies (3 papers). I. Lavi is often cited by papers focused on Spondyloarthritis Studies and Treatments (3 papers), Urinary Tract Infections Management (3 papers) and Rheumatoid Arthritis Research and Therapies (3 papers). I. Lavi collaborates with scholars based in Israel, United States and Czechia. I. Lavi's co-authors include Raanan Raz, Naiel Bisharat, Hussam Omari, Reuven Mader, Gad Rennert, Naomi Gronich, Yoram Kennes, Bibiana Chazan, Raul Colodner and M. Dan and has published in prestigious journals such as Clinical Infectious Diseases, British Journal of Cancer and Annals of the Rheumatic Diseases.

In The Last Decade

I. Lavi

22 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I. Lavi Israel 14 278 276 154 142 139 23 1.1k
Zeynep Birsin Özçakar Türkiye 25 292 1.1× 433 1.6× 319 2.1× 232 1.6× 147 1.1× 127 2.2k
Pankaj Hari India 30 322 1.2× 227 0.8× 382 2.5× 276 1.9× 139 1.0× 154 3.0k
Ajeet Singh Bhadoria India 21 591 2.1× 340 1.2× 98 0.6× 53 0.4× 31 0.2× 127 1.4k
Fatoş Yalçınkaya Türkiye 28 252 0.9× 656 2.4× 363 2.4× 353 2.5× 159 1.1× 136 2.8k
B. Ehlken Germany 21 182 0.7× 222 0.8× 54 0.4× 51 0.4× 41 0.3× 53 1.2k
John Devlin United Kingdom 29 664 2.4× 1.1k 4.0× 61 0.4× 68 0.5× 55 0.4× 66 2.1k
Hefziba Green Israel 14 691 2.5× 183 0.7× 94 0.6× 103 0.7× 27 0.2× 37 1.4k
Yong‐Kwei Tsau Taiwan 20 402 1.4× 183 0.7× 558 3.6× 38 0.3× 200 1.4× 85 1.3k
E Sabbaga Brazil 22 240 0.9× 374 1.4× 149 1.0× 86 0.6× 27 0.2× 136 1.4k
A M Meyers South Africa 21 186 0.7× 337 1.2× 198 1.3× 39 0.3× 35 0.3× 57 1.2k

Countries citing papers authored by I. Lavi

Since Specialization
Citations

This map shows the geographic impact of I. Lavi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Lavi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Lavi more than expected).

Fields of papers citing papers by I. Lavi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. Lavi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Lavi. The network helps show where I. Lavi may publish in the future.

Co-authorship network of co-authors of I. Lavi

This figure shows the co-authorship network connecting the top 25 collaborators of I. Lavi. A scholar is included among the top collaborators of I. Lavi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. Lavi. I. Lavi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dudnik, Elizabeth, I. Lavi, Ofer Rotem, et al.. (2025). The impact of brain MRI screening on stage IV NSCLC patients: A real world look at guidelines based care. Journal of the Neurological Sciences. 470. 123398–123398.
2.
3.
Haddad, Amir, et al.. (2018). THU0288 Implementation of the treat to target concept in evaluation of psoriatic arthritis patients. Annals of the Rheumatic Diseases. 77. 362–363. 1 indexed citations
4.
Rahat, Michal A., Joy Feld, Muna Elias, et al.. (2018). THU0197 Effects of tocilizumab, an anti-interleukin-6 receptor antibody, on serum lipid and adipokine levels in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases. 77. 318–318. 1 indexed citations
5.
Gronich, Naomi, I. Lavi, Ofra Barnett‐Griness, et al.. (2017). Tyrosine kinase-targeting drugs-associated heart failure. British Journal of Cancer. 116(10). 1366–1373. 23 indexed citations
6.
Goldin, Ilya, et al.. (2011). Pain evaluation and control during and following the treatment of hypertrophic scars and keloids by contact and intralesional cryosurgery – a preliminary study. Journal of the European Academy of Dermatology and Venereology. 26(4). 440–447. 21 indexed citations
7.
Gronich, Naomi, I. Lavi, & Gad Rennert. (2011). Higher risk of venous thrombosis associated with drospirenone-containing oral contraceptives: a population-based cohort study. Canadian Medical Association Journal. 183(18). E1319–E1325. 83 indexed citations
8.
Nitzan, Orna, et al.. (2010). Variability in Outpatient Antimicrobial Consumption in Israel. Infection. 38(1). 12–18. 23 indexed citations
9.
Luboshitzky, R., et al.. (2009). Cardiovascular risk factors in primary hyperparathyroidism. Journal of Endocrinological Investigation. 32(4). 317–321. 31 indexed citations
10.
Colodner, Raul, et al.. (2008). Adherence to Guidelines on Empiric Use of Antibiotics in the Emergency Room. Infection. 36(5). 408–414. 13 indexed citations
11.
Mader, Reuven & I. Lavi. (2008). Diabetes mellitus and hypertension as risk factors for early diffuse idiopathic skeletal hyperostosis (DISH). Osteoarthritis and Cartilage. 17(6). 825–828. 74 indexed citations
12.
Ishay, Avraham, I. Lavi, & R. Luboshitzky. (2005). Prevalence and risk factors for asymptomatic bacteriuria in women with Type 2 diabetes mellitus. Diabetic Medicine. 23(2). 185–188. 30 indexed citations
13.
Ben‐Arye, Eran, et al.. (2003). Complementary Medicine and Psoriasis: Linking the Patient’s Outlook with Evidence-Based Medicine. Dermatology. 207(3). 302–307. 57 indexed citations
14.
Rakover, Yardena, et al.. (2002). Can exaggerated response to a GH provocative test identify patients with partial GH insensitivity syndrome?. European Journal of Endocrinology. 146(3). 319–323. 11 indexed citations
15.
16.
Ore, Liora, Lea Hagoel, I. Lavi, & Gad Rennert. (2001). Screening with faecal occult blood test (FOBT) for colorectal cancer: assessment of two methods that attempt to improve compliance. European Journal of Cancer Prevention. 10(3). 251–256. 45 indexed citations
17.
Bisharat, Naiel, Hussam Omari, I. Lavi, & Raanan Raz. (2001). Risk of Infection and Death Among Post-splenectomy Patients. Journal of Infection. 43(3). 182–186. 330 indexed citations
18.
Lavi, I., et al.. (2001). High-level handwashing compliance in a community teaching hospital: a challenge that can be met!. Journal of Hospital Infection. 49(1). 55–58. 40 indexed citations
19.
Rakover, Yardena, et al.. (2000). Comparison Between Four Immunoassays for Growth Hormone (GH) Measurement as Guides to Clinical Decisions Following GH Provocative Tests. Journal of Pediatric Endocrinology and Metabolism. 13(6). 637–43. 12 indexed citations
20.
Raz, Raanan, et al.. (2000). Demographic characteristics of patients with community-acquired bacteriuria and susceptibility of urinary pathogens to antimicrobials in northern Israel.. PubMed. 2(6). 426–9. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zeynep Birsin Özçakar Breakdown of academic impact, for papers by Pankaj Hari Breakdown of academic impact, for papers by Ajeet Singh Bhadoria Breakdown of academic impact, for papers by Fatoş Yalçınkaya Breakdown of academic impact, for papers by B. Ehlken Breakdown of academic impact, for papers by John Devlin Breakdown of academic impact, for papers by Hefziba Green Breakdown of academic impact, for papers by Yong‐Kwei Tsau Breakdown of academic impact, for papers by E Sabbaga Breakdown of academic impact, for papers by A M Meyers
Rankless by CCL
2026